Mitochondrial Iron Metabolism: The Crucial Actors in Diseases

被引:21
作者
Duan, Geyan [1 ,2 ]
Li, Jianjun [1 ,2 ]
Duan, Yehui [1 ,2 ]
Zheng, Changbing [3 ]
Guo, Qiuping [1 ,2 ]
Li, Fengna [1 ,2 ]
Zheng, Jie [1 ,2 ]
Yu, Jiayi [1 ,2 ]
Zhang, Peiwen [3 ]
Wan, Mengliao [3 ]
Long, Cimin [1 ,2 ]
机构
[1] Inst Subtrop Agr, Chinese Acad Sci, CAS Key Lab Agroecol Proc Subtrop Reg, Hunan Prov Key Lab Anim Nutr Physiol & Metab Proc, Changsha 410125, Peoples R China
[2] Univ Chinese Acad Sci, Coll Adv Agr Sci, Beijing 100049, Peoples R China
[3] Hunan Agr Univ, Coll Anim Sci & Technol, Changsha 410128, Peoples R China
来源
MOLECULES | 2023年 / 28卷 / 01期
关键词
iron homeostasis; mitochondrial dysfunction; diseases; CHRONIC HEART-FAILURE; OXIDATIVE STRESS; SKELETAL-MUSCLE; BODY IRON; ALZHEIMERS-DISEASE; FERRIC CARBOXYMALTOSE; REGULATORY PROTEINS; FRIEDREICHS-ATAXIA; HYDROGEN-PEROXIDE; ADIPOSE-TISSUE;
D O I
10.3390/molecules28010029
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Iron is a trace element necessary for cell growth, development, and cellular homeostasis, but insufficient or excessive level of iron is toxic. Intracellularly, sufficient amounts of iron are required for mitochondria (the center of iron utilization) to maintain their normal physiologic function. Iron deficiency impairs mitochondrial metabolism and respiratory activity, while mitochondrial iron overload promotes ROS production during mitochondrial electron transport, thus promoting potential disease development. This review provides an overview of iron homeostasis, mitochondrial iron metabolism, and how mitochondrial iron imbalances-induced mitochondrial dysfunction contribute to diseases.
引用
收藏
页数:18
相关论文
共 179 条
  • [1] Abdelaal Gina, 2021, Oncotarget, V12, P106, DOI 10.18632/oncotarget.27866
  • [2] Iron load and redox stress in skeletal muscle of aged rats
    Altun, Mikael
    Edstrom, Erik
    Spooner, Eric
    Flores-Moralez, Amilcar
    Bergman, Esbjorn
    Tollet-Egnell, Petra
    Norstedt, Gunnar
    Kessler, Benedikt M.
    Ulfhake, Brun
    [J]. MUSCLE & NERVE, 2007, 36 (02) : 223 - 233
  • [3] Medical progress: Disorders of iron metabolism
    Andrews, NC
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (26) : 1986 - 1995
  • [4] Ferric Carboxymaltose in Patients with Heart Failure and Iron Deficiency.
    Anker, Stefan D.
    Comin Colet, Josep
    Filippatos, Gerasimos
    Willenheimer, Ronnie
    Dickstein, Kenneth
    Drexler, Helmut
    Luescher, Thomas F.
    Bart, Boris
    Banasiak, Waldemar
    Niegowska, Joanna
    Kirwan, Bridget-Anne
    Mori, Claudio
    Rothe, Barbara von Eisenhart
    Pocock, Stuart J.
    Poole-Wilson, Philip A.
    Ponikowski, Piotr
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (25) : 2436 - 2448
  • [5] Early Onset Alzheimer's Disease and Oxidative Stress
    Antonio Meraz-Rios, Marco
    Franco-Bocanegra, Diana
    Toral Rios, Danira
    Campos-Pena, Victoria
    [J]. OXIDATIVE MEDICINE AND CELLULAR LONGEVITY, 2014, 2014
  • [6] Cachexia: a problem of energetic inefficiency
    Argiles, Josep M.
    Cristine Fontes-Oliveira, Cibely
    Toledo, Miriam
    Lopez-Soriano, Francisco J.
    Busquets, Silvia
    [J]. JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE, 2014, 5 (04) : 279 - 286
  • [7] DIETARY IRON INTAKE AND RISK OF CORONARY-DISEASE AMONG MEN
    ASCHERIO, A
    WILLETT, WC
    RIMM, EB
    GIOVANNUCCI, EL
    STAMPFER, MJ
    [J]. CIRCULATION, 1994, 89 (03) : 969 - 974
  • [8] Bajbouj Khuloud, 2017, Tumour Biol, V39, p1010428317726184, DOI 10.1177/1010428317726184
  • [9] In vitro and in vivo evidence suggesting a role for iron in cisplatin-induced nephrotoxicity
    Baliga, R
    Zhang, ZW
    Baliga, M
    Ueda, N
    Shah, SV
    [J]. KIDNEY INTERNATIONAL, 1998, 53 (02) : 394 - 401
  • [10] INCREASE IN BLEOMYCIN-DETECTABLE IRON IN ISCHEMIA-REPERFUSION INJURY TO RAT KIDNEYS
    BALIGA, R
    UEDA, N
    SHAH, SV
    [J]. BIOCHEMICAL JOURNAL, 1993, 291 : 901 - 905